Skip to content

Point of Care Nano-Technology, Inc.: 10-Q filed 2013-03-15

What Point of Care Nano-Technology, Inc. reported in its quarterly report filed 2013-03-15 (fiscal Q2 2013): 13 published measures, 47 facts as tagged in accession 0001213900-13-001137.

This filing

Form
10-Q (quarterly report)
Filed
2013-03-15
Fiscal period
fiscal Q2 2013
Accession
0001213900-13-001137 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Point of Care Nano-Technology, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-01-31124USD
At 2012-07-31434USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-01-31226,270USD
At 2012-07-31160,339USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-01-31-226,146USD
At 2012-07-31-159,905USD
At 2011-07-31-31,333USD
At 2010-07-31480,536USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-11-01 to 2013-01-31-31,011USD92
2012-08-01 to 2013-01-31-74,041USD184
2010-06-11 to 2013-01-31-1,017,947USD966
2011-08-01 to 2012-07-31-154,172USD366
2011-11-01 to 2012-01-31-37,835USD92
2011-08-01 to 2012-01-31-88,412USD184
2010-08-01 to 2011-07-31-577,294USD365
2010-06-11 to 2010-07-31-212,440USD51

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-08-01 to 2013-01-31-6,344USD184
2010-06-11 to 2013-01-31-776,611USD966
2011-08-01 to 2012-01-31-25,274USD184

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-08-01 to 2013-01-316,034USD184
2010-06-11 to 2013-01-31776,735USD966
2011-08-01 to 2012-01-3120,000USD184

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-11-01 to 2013-01-31-30,613USD92
2012-08-01 to 2013-01-31-70,652USD184
2010-06-11 to 2013-01-31-1,009,602USD966
2011-11-01 to 2012-01-31-35,380USD92
2011-08-01 to 2012-01-31-84,984USD184

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-11-01 to 2013-01-3130,613USD92
2012-08-01 to 2013-01-3170,652USD184
2010-06-11 to 2013-01-311,009,602USD966
2011-11-01 to 2012-01-3135,380USD92
2011-08-01 to 2012-01-3184,984USD184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-01-3118,077,550shares
At 2012-07-3118,077,550shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-01-31789,993USD
At 2012-07-31782,193USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-11-01 to 2013-01-317,749USD92
2012-08-01 to 2013-01-3115,731USD184
2010-06-11 to 2013-01-3189,462USD966
2011-11-01 to 2012-01-316,407USD92
2011-08-01 to 2012-01-3114,568USD184

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2012-11-01 to 2013-01-31-31,011USD92
2012-08-01 to 2013-01-31-74,041USD184
2010-06-11 to 2013-01-31-1,017,947USD966
2011-11-01 to 2012-01-31-37,835USD92
2011-08-01 to 2012-01-31-88,412USD184

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2010-06-11 to 2013-01-31750,701USD966

Inspect the source

Entity
Point of Care Nano-Technology, Inc. / CIK 0001504239
Captured
2026-09-21T17:20:35.714Z
SEC response SHA-256
47701001bc2f0c3b3da606ab9a58b32bc7a9ae69dd61870f405d9da19992baac

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001504239.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))